5B—Exemption from notification requirements
(1) Pursuant to
section 109(2)(t) of the Act, a medical practitioner is exempt from the
application of section 64(1) of the Act—
(a) in
respect of a suspicion (other than a suspicion formed on the basis of a
point-of-care test) that a person has a designated notifiable condition; or
(ab) in
respect of a suspicion formed on the basis of a point-of-care test that a
person has a designated notifiable condition if the medical practitioner knows
or reasonably believes that a report has already been made to the Chief Public
Health Officer by a pathology service; or
(b) if
the medical practitioner suspects that a person is suffering from a notifiable
AEFI and knows or reasonably believes that a report has already been made to
the Chief Public Health Officer by another medical practitioner or registered
health practitioner of a class prescribed under regulation 5A(1).
(2) In this
regulation—
"designated notifiable condition" means—
(a)
Coronavirus Disease 2019 (COVID-19); or
(b)
Influenza; or
(c)
Respiratory syncytial virus (RSV); or
(d)
Severe Acute Respiratory Syndrome Coronavirus 2 infection (SARS-CoV-2);
or
(e)
Chlamydia trachomatis (sexually transmitted infection only), but only in
relation to a person who is of or over the age of 17 years.